Improving chronic pain care with mindfulness and management visits
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
This study is testing if combining mindfulness practices with personalized pain management visits can help people with chronic pain feel better and reduce their reliance on opioids.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Utah Academic / other |
| Locations | 3 sites (La Jolla, California and 2 other locations) |
| Trial ID | NCT06387290 on ClinicalTrials.gov |
What this trial studies
This trial aims to evaluate the effectiveness of Mindfulness-Oriented Recovery Enhancement (MORE) and patient-centered chronic pain management visits in primary care settings. The focus is on reducing chronic pain, enhancing quality of life, and minimizing opioid-related harms for patients on long-term opioid therapy. Participants will engage in mindfulness practices and receive tailored management visits to address their pain and opioid use. The study will assess the impact of these interventions on patient outcomes over time.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a chronic pain diagnosis and current opioid use for at least three months.
Not a fit: Patients with chronic pain due to cancer or those with active suicidal intent or severe psychiatric disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and quality of life for patients with chronic pain while reducing reliance on opioids.
How similar studies have performed: Other studies have shown promise in using mindfulness-based interventions for chronic pain management, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 + * Current chronic pain diagnosis (pain for ≥3 months) determined by physician assessment * Prescribed long-term opioid therapy (≥3 months) * Score \>=3 on the Pain Enjoyment General Activity scale * Score \>=9 on the Current Opioid Misuse Measure OR lifetime psychiatric or substance use disorder diagnosis OR benzodiazepine use OR history of overdose OR patient or physician determination that risks of opioid use may outweigh the benefits of opioid use Exclusion Criteria: * Chronic pain due to a cancer diagnosis * Active suicidal intent, schizophrenia, psychotic disorder * Prior experience with Mindfulness-Based Stress Reduction, Mindfulness-Based Cognitive Therapy, Mindfulness-Based Relapse Prevention, or Mindfulness-Oriented Recovery Enhancement
Where this trial is running
La Jolla, California and 2 other locations
- UCSD Health — La Jolla, California, United States (Recruiting)
- Rutgers University Primary Care Clinics — New Brunswick, New Jersey, United States (Recruiting)
- University of Utah Primary Care Clinics — Salt Lake City, Utah, United States (Recruiting)
Study contacts
- Study coordinator: Hannah Pfeffer, MSW
- Email: hapfeffer@health.ucsd.edu
- Phone: 619-500-4668
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.